<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Published data on the relationship between E-cadherin (CDH1) gene promoter polymorphisms and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) risk are inconclusive </plain></SENT>
<SENT sid="1" pm="."><plain>To derive a more precise estimation of the relationship, a meta-analysis was carried out </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In this meta-analysis, we evaluated reported studies of associations between polymorphisms of CDH1 gene promoter -160 C &gt; A and -347 G &gt; GA site, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk using fixed-effects model and random-effects model </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: We found decreased <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk among subjects carrying CDH1 -160AA (odds ratio [OR] = 0.86, 95 percent confidence interval [95% CI]: 0.75-0.98) and CA + AA (OR = 0.92, 95% CI: 0.87-0.98), using 4,652/4,428 cases/controls and 7,866/7,689 cases/controls from ten studies, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>We found a protective effect of the CDH1 -160CA + AA polymorphisms for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in distal site <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> population and population-based control in stratified analysis </plain></SENT>
<SENT sid="5" pm="."><plain>We found a protective effect of the CDH1 -160AA and CA + AA polymorphisms for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in European and American population (OR = 0.87, 95% CI: 0.76-0.99 and OR = 0.91, 95% CI: 0.85-0.98, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>We observed that the CDH1 -347 G/GA + GA/GA carrier had an increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, the summary OR was 1.33 (95% CI: 1.08-1.62) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Data indicated that certain CDH1 gene promoter -160 C &gt; A and -347 G &gt; GA variants might affect the susceptibility of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Recommendations for further studies include pooling of individual data to facilitate evaluation of multigenic effects and detailed analysis of effect modification by environmental and lifestyle factors </plain></SENT>
</text></document>